Tag Archives: The Endocrine Society
By Endocrine Society President Teresa K. Woodruff, PhD
The sad stories flow in each day. A post-doctoral fellow gives up scientific research after 10 years of training. A cancer researcher faces a fruitless job search and expiring visa. The endocrinologist agonizes over letting a long-time lab employee go.
Hundreds of these tales are unfolding across the country as the National Institutes of Health struggles to stretch its dwindling budget. Because of sequestration, an NIH budget that barely kept pace with inflation through the 1990s and early 2000s was slashed by another $1.6 billion this fiscal year. If Congress cannot agree on a more balanced approach to budget cuts, another $6.7 billion in needed biomedical research funding will disappear in Fiscal Year 2014. The NIH funding cuts are nothing short of a disaster for biomedical science in the United States, as the Society journal Endocrinology’s Editor-in-Chief Andrea C. Gore observed in a recent editorial.
It is disheartening to think of the treatments that won’t be developed, the discoveries that won’t be made and the patients who will suffer as a result of Congress’ short-sighted funding decisions. As president of The Endocrine Society, I saw firsthand at the Society’s annual meeting ENDO 2013 just how many breakthroughs our researchers are making to ultimately improve the lives of people who have conditions like diabetes, thyroid disorders and cancer. Without biomedical research funding, promising scientific avenues won’t be explored and fewer new treatments will be available to patients in the years to come.
In my own lab at Northwestern University, we instituted a hiring freeze after our grant award was halved. Now we won’t be able to investigate some key questions, such as how endocrine-disrupting chemicals in our environment impact reproductive health.
But there are actions we as researchers and scientists can take to avert the worst effects of this crisis. Congress and the public need to know how much pain the sequester is causing by delaying breakthroughs in treating infertility, heart disease and metabolic disorders. Congress should reverse course. Take a moment to share your story with your Members of Congress, your hometown newspaper, or a health organization like The Endocrine Society, Research!America or United for Medical Research. By raising our voices as one, we can rewrite the story’s ending and protect our nation’s biomedical research legacy.
Dear Research Advocate:
Yesterday, President Obama tweeted about the effects of sequestration on medical research. From @barackobama, “The #sequester is slowing the pace of medical research, delaying the discovery of cures and treatments. Read more.” It is terrific that the president is helping drive increased attention to medical research. Our thanks to him and also to all who have joined our Memorial Day recess week of social media advocacy. The American Heart Association posted this great image to its Facebook page; we also thank Society for Neuroscience, BIO, The Endocrine Society, Melanoma Research Alliance, University of Maryland School of Medicine, CURE Epilepsy and UPenn Science Policy — among many others — who have participated. Now it’s your turn; let’s kick this campaign into high gear as we wrap up the week!
We know from our regularly commissioned polls that Americans value the work of our taxpayer-supported health agencies. In a recent Gallup poll, the CDC received the best reviews among 10 federal agencies surveyed. Take advantage of this news hook to translate public support into policy-maker action. CDC funding has been subjected to budget cut after budget cut, compromising the agency’s ability to safeguard the health of Americans against pandemics, bioterrorism, drug-resistant strains of infectious disease, and other predictable and unpredictable public health threats. Everyday Americans appear to value CDC more than our policy makers do. Tell your elected representatives: Let’s get past this disconnect; stand up for the CDC.
Research!America has been highlighting the importance of tackling global killers like HIV/AIDS, malaria, TB and neglected tropical diseases (NTDs) during USAID’s Global Health Month. Elected officials and the policy media are often surprised to learn that global health research and development is an integral part of the public and private sector-funded research enterprise in this country. The National Law Review’s coverage (article) of global health has highlighted Research!America’s Top 10 Reasons Why the U.S. Should Invest in Global Health Research & Development. Check it out, and if it whets your appetite for more, take a look at our video about NTDs. Typically not thought of as a problem in the U.S., NTDs are now a significant threat here. We simply must put research to work to stay ahead of the curve — to help our international friends and to maintain health and prosperity at home.